Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:55 AM
Ignite Modification Date: 2025-12-25 @ 11:10 PM
NCT ID: NCT00853567
Description: No adverse events data is available.
Frequency Threshold: 5
Time Frame: None
Study: NCT00853567
Study Brief: Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
25 g Proellex 25 mg oral daily dose of Proellex Proellex: 25 mg oral daily dose vs. 50 mg oral daily dose vs. placebo None None 0 0 0 0 View
50 mg Proellex 50 mg oral daily dose of Proellex Proellex: 25 mg oral daily dose vs. 50 mg oral daily dose vs. placebo None None 0 0 0 0 View
Placebo Placebo treatment placebo: Placebo None None 0 0 0 0 View
Serious Events(If Any):
Other Events(If Any):